Results 21 to 30 of about 11,994 (242)
Micafungin: a sulfated echinocandin [PDF]
The Journal of Antibiotics, 2009 AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
Seiji Hashimoto
openalex +4 more sources
Treatment of Candiduria with Micafungin: A Case Series [PDF]
Canadian Journal of Infectious Diseases and Medical Microbiology, 2006 There has been a gradual increase in the incidence of non‐Candida albicans‐related nosocomial infections. Candida glabrata urinary tract infections have increased in frequency, and treating these infections can be difficult because the organism may be resistant to fluconazole.
Danny D Lagrotteria +2 more
openalex +6 more sources
Improving the production of the micafungin precursor FR901379 in an industrial production strain
Microbial Cell Factories, 2023 Background Micafungin is an echinocandin-type antifungal agent used for the clinical treatment of invasive fungal infections. It is semisynthesized from the sulfonated lipohexapeptide FR901379, a nonribosomal peptide produced by the filamentous fungus ...
P. Men +6 more
semanticscholar +1 more source
AMB Express, 2023 The prevalence of antibiotic resistance in Pseudomonas aeruginosa places a heavy burden on the health care sectors urging the need to find alternative, non-antibiotic strategies. The interference with the P.
Duaa M. Hijazi +4 more
semanticscholar +1 more source
Antimicrobial Agents and Chemotherapy, 2023 Candida (Clavispora) lusitaniae is a rare, emerging non-albicans Candida species that can cause life-threatening invasive infections, spread within hospital settings, and rapidly acquire antifungal drug resistance, including multidrug resistance.
N. E. Scott +3 more
semanticscholar +1 more source
Urinothorax With Fungal Empyema-A Rare and Unique Combination. [PDF]
Respirol Case RepThis case describes a patient presenting with symptomatic unilateral pleural effusion after a urological procedure which was initially treated and resolved. It subsequently recurred and was complicated by fungal pleural infection. It was treated as urinothorax.
Rashid Ali MRS, Meng TT.
europepmc +2 more sources
Antimicrobial Agents and Chemotherapy, 2023 Procedures such as solid-organ transplants and cancer treatments can leave many patients in an immunocompromised state. This leads to their increased susceptibility to opportunistic diseases such as fungal infections.
Alexis García, E. Huh, Soo Chan Lee
semanticscholar +1 more source
Antimicrobial Agents and Chemotherapy, 2022 Candida bloodstream infections are associated with high attributable mortality, where early initiation of adequate antifungal therapy is important to increase survival in critically ill patients. The exposure variability of micafungin, a first-line agent
J. Boonstra +5 more
semanticscholar +1 more source
Micafungin: A New Echinocandin [PDF]
Clinical Infectious Diseases, 2006 Micafungin, a potent inhibitor of 1,3-beta-D-glucan synthase, has become the second available agent in the echinocandins class that is approved for use in clinical practice. This agent shares with caspofungin an identical spectrum of in vitro activity against Candida albicans, non-albicans species of Candida, and Aspergillus species, as well as several
Jack D. Sobel +1 more
openaire +3 more sources
Microorganisms, 2021 Candida auris is an emerging and frequently multidrug-resistant pathogen against which the echinocandins are the preferred therapeutic option. We compared killing activities of anidulafungin, caspofungin, micafungin, and rezafungin against 13 isolates ...
R. Kovács +7 more
semanticscholar +1 more source